Google’s DeepMind puts human proteome online for freeThe most complete database of protein structures ever assembled, developed with the help of Google’s artificial intelligence unit Share XGoogle’s DeepMind puts human proteome online for freehttps://pharmaphorum.com/news/googles-deepmind-puts-human-proteome-online-for-free/
Gates Foundation backs COVID R&D at AI firm ExscientiaArtificial intelligence-based drug discovery company Exscientia is stepping up its search for new COVID-19 medicines, thanks to an Share XGates Foundation backs COVID R&D at AI firm Exscientiahttps://pharmaphorum.com/news/gates-foundation-backs-covid-rd-at-ai-firm-exscientia/
BMS embraces AI drug discovery with $1.2bn Exscientia allianceExscientia has signed up another big pharma partner for its artificial intelligence (AI) based drug discovery platform, this Share XBMS embraces AI drug discovery with $1.2bn Exscientia alliancehttps://pharmaphorum.com/news/bms-embraces-ai-drug-discovery-with-1-2bn-exscientia-alliance/
Exscientia starts trials of AI-designed Alzheimer’s drugExscientia has advanced a drug candidate for Alzheimer’s disease into human testing, the third clinical-stage project for the Share XExscientia starts trials of AI-designed Alzheimer’s drughttps://pharmaphorum.com/news/exscientia-starts-clinical-trials-of-ai-designed-alzheimers-drug/
Exscientia starts trials of first AI-derived cancer immunotherapyExscientia was the first company to start human trials of a new drug designed using artificial intelligence (AI) Share XExscientia starts trials of first AI-derived cancer immunotherapyhttps://pharmaphorum.com/news/exscientia-starts-trials-of-first-ai-derived-cancer-immunotherapy/
AI drug discovery player 1910 Genetics debuts with $26m war chestThere’s a new kid on the block among companies using artificial intelligence in drug discovery, after 1910 Genetics Share XAI drug discovery player 1910 Genetics debuts with $26m war chesthttps://pharmaphorum.com/news/ai-drug-discovery-player-1910-genetics-debits-with-26m-war-chest/
Protein misfolding specialist Gain nets $40m from IPOGain Therapeutics has priced its initial public offering, raising more than $40 million for its computational drug discovery Share XProtein misfolding specialist Gain nets $40m from IPOhttps://pharmaphorum.com/news/protein-misfolding-specialist-gain-nets-40m-from-ipo/
Welsh startup Antiverse raises $2m for antibody discovery toolkitNew biotech Antiverse has raised seed funding of £1.4 million ($2 million) to develop its artificial intelligence-based platform Share XWelsh startup Antiverse raises $2m for antibody discovery toolkithttps://pharmaphorum.com/news/welsh-startup-antiverse-raises-2m-for-antibody-discovery-toolkit/
AI drug discovery firm Valence joins Parkinson’s disease pushCanada’s Valence Discovery has joined a University of Montreal-led project to try to find new drugs to treat Share XAI drug discovery firm Valence joins Parkinson’s disease pushhttps://pharmaphorum.com/news/ai-drug-discovery-firm-valence-joins-parkinsons-disease-push/
